The results of a large, randomized, North American trial (SWOG S0124) that compared etoposide and cisplatin with irinotecan and cisplatin for patients with extensive small-cell lung cancer have failed to confirm the benefit observed with irinotecan that was demonstrated in an earlier Japan Clinical Oncology Group study (JCOG 9511).
- Faye M. Johnson
- Bonnie S. Glisson
